Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2026)

Viemed Healthcare (VMD) has reported Current Deferred Revenue for 9 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue rose 11.26% year-over-year to $8.0 million; the trailing twelve-month figure through Jun 2026 stood at $8.0 million (up 11.26% YoY), and the FY2025 full-year result was $7.5 million, up 12.34% from the prior year.
• Current Deferred Revenue advanced to $8.0 million in Q2 2026 per VMD's latest filing, from $7.5 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $8.0 million in Q2 2026 and bottomed at $3.9 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $6.2 million across 5 years, with a median of $6.5 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue soared 35.39% in 2023, then climbed 6.99% in 2025.
• Over 5 years, Current Deferred Revenue stood at $4.6 million in 2022, then jumped by 34.23% to $6.2 million in 2023, then gained by 7.85% to $6.7 million in 2024, then climbed by 12.34% to $7.5 million in 2025, then gained by 6.42% to $8.0 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $8.0 million, $7.5 million, and $7.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.